Annealing Furnaces
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Anti-PD-1 Antibody Market Research Report 2023
1 Anti-PD-1 Antibody Market Overview
1.1 Product Overview and Scope of Anti-PD-1 Antibody
1.2 Anti-PD-1 Antibody Segment by Type
1.2.1 Global Anti-PD-1 Antibody Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Anti-PD-1 Antibody Segment by Application
1.3.1 Global Anti-PD-1 Antibody Sales Comparison by Application: (2022-2028)
1.3.2 IHC-P
1.3.3 ICC/IF
1.3.4 WB
1.3.5 Flow Cytometry
1.3.6 ELISA
1.4 Global Anti-PD-1 Antibody Market Size Estimates and Forecasts
1.4.1 Global Anti-PD-1 Antibody Revenue 2017-2028
1.4.2 Global Anti-PD-1 Antibody Sales 2017-2028
1.4.3 Anti-PD-1 Antibody Market Size by Region: 2017 Versus 2021 Versus 2028
2 Anti-PD-1 Antibody Market Competition by Manufacturers
2.1 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2017-2022)
2.2 Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Anti-PD-1 Antibody Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Anti-PD-1 Antibody Manufacturing Sites, Area Served, Product Type
2.5 Anti-PD-1 Antibody Market Competitive Situation and Trends
2.5.1 Anti-PD-1 Antibody Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Anti-PD-1 Antibody Players Market Share by Revenue
2.5.3 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anti-PD-1 Antibody Retrospective Market Scenario by Region
3.1 Global Anti-PD-1 Antibody Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Anti-PD-1 Antibody Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Anti-PD-1 Antibody Market Facts & Figures by Country
3.3.1 North America Anti-PD-1 Antibody Sales by Country
3.3.2 North America Anti-PD-1 Antibody Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Anti-PD-1 Antibody Market Facts & Figures by Country
3.4.1 Europe Anti-PD-1 Antibody Sales by Country
3.4.2 Europe Anti-PD-1 Antibody Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Anti-PD-1 Antibody Market Facts & Figures by Region
3.5.1 Asia Pacific Anti-PD-1 Antibody Sales by Region
3.5.2 Asia Pacific Anti-PD-1 Antibody Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Anti-PD-1 Antibody Market Facts & Figures by Country
3.6.1 Latin America Anti-PD-1 Antibody Sales by Country
3.6.2 Latin America Anti-PD-1 Antibody Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Anti-PD-1 Antibody Market Facts & Figures by Country
3.7.1 Middle East and Africa Anti-PD-1 Antibody Sales by Country
3.7.2 Middle East and Africa Anti-PD-1 Antibody Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Anti-PD-1 Antibody Historic Market Analysis by Type
4.1 Global Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)
4.2 Global Anti-PD-1 Antibody Revenue Market Share by Type (2017-2022)
4.3 Global Anti-PD-1 Antibody Price by Type (2017-2022)
5 Global Anti-PD-1 Antibody Historic Market Analysis by Application
5.1 Global Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)
5.2 Global Anti-PD-1 Antibody Revenue Market Share by Application (2017-2022)
5.3 Global Anti-PD-1 Antibody Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Bio X Cell
6.1.1 Bio X Cell Corporation Information
6.1.2 Bio X Cell Description and Business Overview
6.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Bio X Cell Anti-PD-1 Antibody Product Portfolio
6.1.5 Bio X Cell Recent Developments/Updates
6.2 Thermo Fisher
6.2.1 Thermo Fisher Corporation Information
6.2.2 Thermo Fisher Description and Business Overview
6.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Thermo Fisher Anti-PD-1 Antibody Product Portfolio
6.2.5 Thermo Fisher Recent Developments/Updates
6.3 InvivoGen
6.3.1 InvivoGen Corporation Information
6.3.2 InvivoGen Description and Business Overview
6.3.3 InvivoGen Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.3.4 InvivoGen Anti-PD-1 Antibody Product Portfolio
6.3.5 InvivoGen Recent Developments/Updates
6.4 BioVision Inc
6.4.1 BioVision Inc Corporation Information
6.4.2 BioVision Inc Description and Business Overview
6.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.4.4 BioVision Inc Anti-PD-1 Antibody Product Portfolio
6.4.5 BioVision Inc Recent Developments/Updates
6.5 Abcam
6.5.1 Abcam Corporation Information
6.5.2 Abcam Description and Business Overview
6.5.3 Abcam Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Abcam Anti-PD-1 Antibody Product Portfolio
6.5.5 Abcam Recent Developments/Updates
6.6 Bristol-Myers Squibb (BMS)
6.6.1 Bristol-Myers Squibb (BMS) Corporation Information
6.6.2 Bristol-Myers Squibb (BMS) Description and Business Overview
6.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Portfolio
6.6.5 Bristol-Myers Squibb (BMS) Recent Developments/Updates
6.7 Merck
6.6.1 Merck Corporation Information
6.6.2 Merck Description and Business Overview
6.6.3 Merck Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Anti-PD-1 Antibody Product Portfolio
6.7.5 Merck Recent Developments/Updates
6.8 Ono Pharmaceutical Co., Ltd
6.8.1 Ono Pharmaceutical Co., Ltd Corporation Information
6.8.2 Ono Pharmaceutical Co., Ltd Description and Business Overview
6.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
6.8.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
6.9 Lilly
6.9.1 Lilly Corporation Information
6.9.2 Lilly Description and Business Overview
6.9.3 Lilly Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Lilly Anti-PD-1 Antibody Product Portfolio
6.9.5 Lilly Recent Developments/Updates
6.10 Chugai Pharmaceutical Co., Ltd
6.10.1 Chugai Pharmaceutical Co., Ltd Corporation Information
6.10.2 Chugai Pharmaceutical Co., Ltd Description and Business Overview
6.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Portfolio
6.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
6.11 BeiGene
6.11.1 BeiGene Corporation Information
6.11.2 BeiGene Anti-PD-1 Antibody Description and Business Overview
6.11.3 BeiGene Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.11.4 BeiGene Anti-PD-1 Antibody Product Portfolio
6.11.5 BeiGene Recent Developments/Updates
6.12 Abbvie
6.12.1 Abbvie Corporation Information
6.12.2 Abbvie Anti-PD-1 Antibody Description and Business Overview
6.12.3 Abbvie Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Abbvie Anti-PD-1 Antibody Product Portfolio
6.12.5 Abbvie Recent Developments/Updates
6.13 TG Therapeutics, Inc
6.13.1 TG Therapeutics, Inc Corporation Information
6.13.2 TG Therapeutics, Inc Anti-PD-1 Antibody Description and Business Overview
6.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Product Portfolio
6.13.5 TG Therapeutics, Inc Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Anti-PD-1 Antibody Description and Business Overview
6.14.3 Novartis Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Novartis Anti-PD-1 Antibody Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Arcus Biosciences
6.15.1 Arcus Biosciences Corporation Information
6.15.2 Arcus Biosciences Anti-PD-1 Antibody Description and Business Overview
6.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Arcus Biosciences Anti-PD-1 Antibody Product Portfolio
6.15.5 Arcus Biosciences Recent Developments/Updates
6.16 Sino Biological Inc
6.16.1 Sino Biological Inc Corporation Information
6.16.2 Sino Biological Inc Anti-PD-1 Antibody Description and Business Overview
6.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Sino Biological Inc Anti-PD-1 Antibody Product Portfolio
6.16.5 Sino Biological Inc Recent Developments/Updates
6.17 3SBio Inc
6.17.1 3SBio Inc Corporation Information
6.17.2 3SBio Inc Anti-PD-1 Antibody Description and Business Overview
6.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Revenue and Gross Margin (2017-2022)
6.17.4 3SBio Inc Anti-PD-1 Antibody Product Portfolio
6.17.5 3SBio Inc Recent Developments/Updates
7 Anti-PD-1 Antibody Manufacturing Cost Analysis
7.1 Anti-PD-1 Antibody Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Anti-PD-1 Antibody
7.4 Anti-PD-1 Antibody Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Anti-PD-1 Antibody Distributors List
8.3 Anti-PD-1 Antibody Customers
9 Anti-PD-1 Antibody Market Dynamics
9.1 Anti-PD-1 Antibody Industry Trends
9.2 Anti-PD-1 Antibody Market Drivers
9.3 Anti-PD-1 Antibody Market Challenges
9.4 Anti-PD-1 Antibody Market Restraints
10 Global Market Forecast
10.1 Anti-PD-1 Antibody Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Anti-PD-1 Antibody by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Type (2023-2028)
10.2 Anti-PD-1 Antibody Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Anti-PD-1 Antibody by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Application (2023-2028)
10.3 Anti-PD-1 Antibody Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Anti-PD-1 Antibody by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Anti-PD-1 Antibody by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Anti-PD-1 Antibody Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Anti-PD-1 Antibody Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Anti-PD-1 Antibody Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Anti-PD-1 Antibody Market Competitive Situation by Manufacturers in 2021
Table 5. Global Anti-PD-1 Antibody Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Anti-PD-1 Antibody Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Anti-PD-1 Antibody Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Anti-PD-1 Antibody Average Price (USD/g) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Anti-PD-1 Antibody Manufacturing Sites and Area Served
Table 11. Manufacturers Anti-PD-1 Antibody Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-PD-1 Antibody as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Anti-PD-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 16. Global Anti-PD-1 Antibody Sales Market Share by Region (2017-2022)
Table 17. Global Anti-PD-1 Antibody Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Anti-PD-1 Antibody Revenue Market Share by Region (2017-2022)
Table 19. North America Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 20. North America Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)
Table 21. North America Anti-PD-1 Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)
Table 23. Europe Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 24. Europe Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)
Table 25. Europe Anti-PD-1 Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Anti-PD-1 Antibody Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Anti-PD-1 Antibody Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Anti-PD-1 Antibody Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Anti-PD-1 Antibody Revenue Market Share by Region (2017-2022)
Table 31. Latin America Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)
Table 33. Latin America Anti-PD-1 Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Anti-PD-1 Antibody Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Anti-PD-1 Antibody Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Anti-PD-1 Antibody Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Anti-PD-1 Antibody Revenue Market Share by Country (2017-2022)
Table 39. Global Anti-PD-1 Antibody Sales by Type (2017-2022) & (Kg)
Table 40. Global Anti-PD-1 Antibody Sales Market Share by Type (2017-2022)
Table 41. Global Anti-PD-1 Antibody Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Anti-PD-1 Antibody Revenue Share by Type (2017-2022)
Table 43. Global Anti-PD-1 Antibody Price by Type (2017-2022) & (USD/g)
Table 44. Global Anti-PD-1 Antibody Sales (Kg) by Application (2017-2022)
Table 45. Global Anti-PD-1 Antibody Sales Market Share by Application (2017-2022)
Table 46. Global Anti-PD-1 Antibody Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Anti-PD-1 Antibody Revenue Share by Application (2017-2022)
Table 48. Global Anti-PD-1 Antibody Price by Application (2017-2022) & (USD/g)
Table 49. Bio X Cell Corporation Information
Table 50. Bio X Cell Description and Business Overview
Table 51. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 52. Bio X Cell Anti-PD-1 Antibody Product
Table 53. Bio X Cell Recent Developments/Updates
Table 54. Thermo Fisher Corporation Information
Table 55. Thermo Fisher Description and Business Overview
Table 56. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 57. Thermo Fisher Anti-PD-1 Antibody Product
Table 58. Thermo Fisher Recent Developments/Updates
Table 59. InvivoGen Corporation Information
Table 60. InvivoGen Description and Business Overview
Table 61. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 62. InvivoGen Anti-PD-1 Antibody Product
Table 63. InvivoGen Recent Developments/Updates
Table 64. BioVision Inc Corporation Information
Table 65. BioVision Inc Description and Business Overview
Table 66. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 67. BioVision Inc Anti-PD-1 Antibody Product
Table 68. BioVision Inc Recent Developments/Updates
Table 69. Abcam Corporation Information
Table 70. Abcam Description and Business Overview
Table 71. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 72. Abcam Anti-PD-1 Antibody Product
Table 73. Abcam Recent Developments/Updates
Table 74. Bristol-Myers Squibb (BMS) Corporation Information
Table 75. Bristol-Myers Squibb (BMS) Description and Business Overview
Table 76. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 77. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product
Table 78. Bristol-Myers Squibb (BMS) Recent Developments/Updates
Table 79. Merck Corporation Information
Table 80. Merck Description and Business Overview
Table 81. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 82. Merck Anti-PD-1 Antibody Product
Table 83. Merck Recent Developments/Updates
Table 84. Ono Pharmaceutical Co., Ltd Corporation Information
Table 85. Ono Pharmaceutical Co., Ltd Description and Business Overview
Table 86. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 87. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 88. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 89. Lilly Corporation Information
Table 90. Lilly Description and Business Overview
Table 91. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 92. Lilly Anti-PD-1 Antibody Product
Table 93. Lilly Recent Developments/Updates
Table 94. Chugai Pharmaceutical Co., Ltd Corporation Information
Table 95. Chugai Pharmaceutical Co., Ltd Description and Business Overview
Table 96. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 97. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product
Table 98. Chugai Pharmaceutical Co., Ltd Recent Developments/Updates
Table 99. BeiGene Corporation Information
Table 100. BeiGene Description and Business Overview
Table 101. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 102. BeiGene Anti-PD-1 Antibody Product
Table 103. BeiGene Recent Developments/Updates
Table 104. Abbvie Corporation Information
Table 105. Abbvie Description and Business Overview
Table 106. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 107. Abbvie Anti-PD-1 Antibody Product
Table 108. Abbvie Recent Developments/Updates
Table 109. TG Therapeutics, Inc Corporation Information
Table 110. TG Therapeutics, Inc Description and Business Overview
Table 111. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 112. TG Therapeutics, Inc Anti-PD-1 Antibody Product
Table 113. TG Therapeutics, Inc Recent Developments/Updates
Table 114. Novartis Corporation Information
Table 115. Novartis Description and Business Overview
Table 116. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 117. Novartis Anti-PD-1 Antibody Product
Table 118. Novartis Recent Developments/Updates
Table 119. Arcus Biosciences Corporation Information
Table 120. Arcus Biosciences Description and Business Overview
Table 121. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 122. Arcus Biosciences Anti-PD-1 Antibody Product
Table 123. Arcus Biosciences Recent Developments/Updates
Table 124. Sino Biological Inc Corporation Information
Table 125. Sino Biological Inc Description and Business Overview
Table 126. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 127. Sino Biological Inc Anti-PD-1 Antibody Product
Table 128. Sino Biological Inc Recent Developments/Updates
Table 129. 3SBio Inc Corporation Information
Table 130. 3SBio Inc Description and Business Overview
Table 131. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2017-2022)
Table 132. 3SBio Inc Anti-PD-1 Antibody Product
Table 133. 3SBio Inc Recent Developments/Updates
Table 134. Production Base and Market Concentration Rate of Raw Material
Table 135. Key Suppliers of Raw Materials
Table 136. Anti-PD-1 Antibody Distributors List
Table 137. Anti-PD-1 Antibody Customers List
Table 138. Anti-PD-1 Antibody Market Trends
Table 139. Anti-PD-1 Antibody Market Drivers
Table 140. Anti-PD-1 Antibody Market Challenges
Table 141. Anti-PD-1 Antibody Market Restraints
Table 142. Global Anti-PD-1 Antibody Sales Forecast by Type (2023-2028) & (Kg)
Table 143. Global Anti-PD-1 Antibody Sales Market Share Forecast by Type (2023-2028)
Table 144. Global Anti-PD-1 Antibody Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 145. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Type (2023-2028)
Table 146. Global Anti-PD-1 Antibody Sales Forecast by Application (2023-2028) & (Kg)
Table 147. Global Anti-PD-1 Antibody Sales Market Share Forecast by Application (2023-2028)
Table 148. Global Anti-PD-1 Antibody Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 149. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Application (2023-2028)
Table 150. Global Anti-PD-1 Antibody Sales Forecast by Region (2023-2028) & (Kg)
Table 151. Global Anti-PD-1 Antibody Sales Market Share Forecast by Region (2023-2028)
Table 152. Global Anti-PD-1 Antibody Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 153. Global Anti-PD-1 Antibody Revenue Market Share Forecast by Region (2023-2028)
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Anti-PD-1 Antibody
Figure 2. Global Anti-PD-1 Antibody Market Share by Type in 2021 & 2028
Figure 3. Monoclonal Product Picture
Figure 4. Polyclonal Product Picture
Figure 5. Global Anti-PD-1 Antibody Market Share by Application in 2021 & 2028
Figure 6. IHC-P
Figure 7. ICC/IF
Figure 8. WB
Figure 9. Flow Cytometry
Figure 10. ELISA
Figure 11. Global Anti-PD-1 Antibody Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Anti-PD-1 Antibody Market Size (2017-2028) & (US$ Million)
Figure 13. Global Anti-PD-1 Antibody Sales (2017-2028) & (Kg)
Figure 14. Anti-PD-1 Antibody Sales Share by Manufacturers in 2021
Figure 15. Global Anti-PD-1 Antibody Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Anti-PD-1 Antibody Players: Market Share by Revenue in 2021
Figure 17. Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Anti-PD-1 Antibody Sales Market Share by Region (2017-2022)
Figure 19. Global Anti-PD-1 Antibody Sales Market Share by Region in 2021
Figure 20. Global Anti-PD-1 Antibody Revenue Market Share by Region (2017-2022)
Figure 21. Global Anti-PD-1 Antibody Revenue Market Share by Region in 2021
Figure 22. U.S. Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Anti-PD-1 Antibody Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Anti-PD-1 Antibody by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Anti-PD-1 Antibody
Figure 48. Manufacturing Process Analysis of Anti-PD-1 Antibody
Figure 49. Anti-PD-1 Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bio X Cell Thermo Fisher InvivoGen BioVision Inc Abcam Bristol-Myers Squibb (BMS) Merck Ono Pharmaceutical Co., Ltd Lilly Chugai Pharmaceutical Co., Ltd BeiGene Abbvie TG Therapeutics, Inc Novartis Arcus Biosciences Sino Biological Inc 3SBio Inc